DCM
DVAX

Dupont Capital Management’s Dynavax Technologies DVAX Stock Holding History

Dupont Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-60,159
Closed -$591K – 1754
2021
Q1 		$591K Sell
60,159
-74,613
-55% -$615K 0.01% 842
2020
Q4 		$600K Buy
134,772
+88,042
+188% +$399K 0.01% 773
2020
Q3 		$202K Buy
+46,730
New +$333K ﹤0.01% 1118

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Dupont Capital Management's DVAX Position: Q2 2021 in Review

Dupont Capital Management sold out of Dynavax Technologies (DVAX) in Q2 2021, closing a stake of 60,159 shares — an estimated $591K sold.

Dupont Capital Management first reported a position in DVAX in Q3 2020 and held it in 3 quarters. The position peaked at $600K in Q4 2020. 154 funds tracked by Wall St. Rank hold DVAX as of Q2 2021.

  • Dupont Capital Management reported no remaining Dynavax Technologies position as of Q2 2021 after selling out during the quarter.
  • Dupont Capital Management sold 60,159 Dynavax Technologies shares in Q2 2021, an estimated $591K.
  • Dupont Capital Management first reported a position in Dynavax Technologies in Q3 2020 and held it in 3 quarters.
  • Dupont Capital Management's Dynavax Technologies position peaked at $600K in Q4 2020.
  • 154 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2021.

Based on Dupont Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.